Table 2

Age-adjusted and sex-adjusted associations of high spectrum signal intensity coefficient with clinical risk factors and echocardiographic markers

	Total sample			Women			Men
	Est.	SE	P value	Est.	SE	P value	Est.	SE	P value
Female sex*	−0.43	0.04	<0.0001	–	–		–	–
Age (per SD)*	0.16	0.02	<0.0001	0.14	0.02	<0.0001	0.18	0.03	<0.0001
Body mass index (per SD)	0.34	0.02	<0.0001	0.31	0.02	<0.0001	0.39	0.03	<0.0001
Total/HDL cholesterol (per SD)	0.15	0.02	<0.0001	0.18	0.07	<0.0001	0.13	0.03	<0.0001
Systolic blood pressure (per SD)	0.04	0.02	0.05	0.08	0.03	<0.01	−0.02	0.03	0.64
Antihypertensive treatment	0.21	0.04	<0.0001	0.25	0.05	<0.0001	0.16	0.06	0.01
Diabetes	0.40	0.06	<0.0001	0.47	0.09	<0.0001	0.35	0.09	<0.0001
Smoking	0.03	0.07	0.66	0.06	0.08	0.46	−0.02	0.12	0.85
LVEF (per SD)	−0.01	0.003	0.01	−0.01	0.004	0.02	−0.01	0.005	0.16
E/e’ measurement (per SD)	0.02	0.01	0.07	0.01	0.01	0.55	0.04	0.02	0.03

*Models including sex were adjusted for age only, and models including age were adjusted for sex only.
HDL, high-density lipoprotein; LVEF, left ventricular ejection fraction.